NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN)

 
SONN Technical Analysis
4
As on 3rd Jul 2025 SONN STOCK Price closed @ 3.92 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.94 & Strong Buy for SHORT-TERM with Stoploss of 1.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SONNSTOCK Price

Open 3.65 Change Price %
High 4.14 1 Day -0.23 -5.54
Low 3.10 1 Week 2.77 240.87
Close 3.92 1 Month 2.62 201.54
Volume 6198942 1 Year 2.58 192.54
52 Week High 6.69 | 52 Week Low 0.66
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.16 5.37%
HCTI 0.03 50.00%
NVDA 159.34 1.33%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 1.47 5.00%
WINT 0.93 20.78%
BTBT 2.94 11.79%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.22 -77.08%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
SONN
Daily Charts
SONN
Intraday Charts
Whats New @
Bazaartrend
SONN
Free Analysis
 
SONN Important Levels Intraday
RESISTANCE5.92
RESISTANCE5.28
RESISTANCE4.88
RESISTANCE4.49
SUPPORT3.35
SUPPORT2.96
SUPPORT2.56
SUPPORT1.92
 
SONN Forecast July 2025
4th UP Forecast5.71
3rd UP Forecast5.14
2nd UP Forecast4.78
1st UP Forecast4.43
1st DOWN Forecast3.41
2nd DOWN Forecast3.06
3rd DOWN Forecast2.7
4th DOWN Forecast2.13
 
SONN Weekly Forecast
4th UP Forecast4.36
3rd UP Forecast4.22
2nd UP Forecast4.13
1st UP Forecast4.05
1st DOWN Forecast3.79
2nd DOWN Forecast3.71
3rd DOWN Forecast3.62
4th DOWN Forecast3.48
 
SONN Forecast2025
4th UP Forecast22.03
3rd UP Forecast16.22
2nd UP Forecast12.63
1st UP Forecast9.04
1st DOWN Forecast-1.2
2nd DOWN Forecast-4.79
3rd DOWN Forecast-8.38
4th DOWN Forecast-14.19
 
 
SONN Other Details
Segment EQ
Market Capital 37472116.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SONN Address
SONN
 
SONN Latest News
 
Your Comments and Response on Sonnet BioTherapeutics Holdings Inc
 
SONN Business Profile
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey. Address: 100 Overlook Center, Princeton, NJ, United States, 08540
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service